Canada Post Xpresspost within Canada: $25.00 flat rate; free on product subtotals of $299.00 or more · Interac e-Transfer

BlueNex Labs

Research · 2026-04-12

Scientific lead: Alice Kay, Ph.D.

Grey Market Peptides Canada

Direct answer

How laboratory purchasers compare lot-specific third-party reports and domestic fulfilment with undocumented peptide parcels. Educational note — not a ranking of vendors.

Scope

COA, quality & sourcing. How to read batch reports, compare supply channels, and document identity, purity, and endotoxin.

Reviewer: Alice Kay, Ph.D., scientific lead. This note does not claim that the reviewer authored any cited paper.

Illustration: Grey Market Peptides Canada

Research-use notice: This article is laboratory and educational information only. It is not medical or legal advice, and it does not include how-to-use instructions. BlueNex Labs materials are research use only and are not intended for human or veterinary use. Research-use-only labelling is not a Health Canada authorization.

Laboratory purchasers in Canada often compare two supply patterns: a domestic research-use-only catalogue that publishes lot-specific third-party reports, and parcels whose identity, purity, and chain of custody cannot be opened by the buyer. This note describes that documentation difference. It is not a consumer shopping guide, not a ranking of vendors, and not a claim that BlueNex Labs is a compounding pharmacy or a GMP drug manufacturer.

What “documented” means on this site

BlueNex Labs is a Canadian RUO catalogue. Operational facts a purchasing office can check:

  • Canada-only fulfilment after Interac e-Transfer checkout.
  • Public desk in Burnaby, B.C.; Canada Post Xpresspost labels from a Port Moody PO Box.
  • Lot reports, when published, in the Certificate of Analysis library, typically Janoshik identity and purity (mass), with endotoxin on some lots.
  • Research-use-only labelling. Not for human or veterinary use.

Those documents support laboratory receiving. They are not a Health Canada drug authorization, a sterility warranty, or evidence of a compounding-pharmacy licence.

What an unverified parcel usually lacks

A purchaser who cannot open a lot-specific identity and purity report, cannot match a batch number to that report, or cannot confirm a Canadian fulfilment path is working with incomplete documentation. Secondary “COA” images that are not lot-specific, not from a named laboratory, or not tied to the vial in hand do not replace a report the buyer can verify.

This article does not invent country-of-origin statistics or name overseas factories. Intended use and advertising still matter under Canadian law regardless of where a powder was synthesized. See Are research peptides legal in Canada?.

What we do not claim

BlueNex Labs does not claim to be a licensed compounding facility, does not claim GMP drug manufacture, and does not claim sterility of a lyophilized research solid unless a published report for that lot says so. Older copy that framed this catalogue as a compounding pharmacy was incorrect and is not used here.

Catalogue cross-reference

For current SKUs open the shop. For lot reports open the COA library. Judge supply by documents you can open, not by leftover comparison-blog language.

Orders ship inside Canada only after Interac e-Transfer checkout. Sold-out SKUs remain listed and cannot be added to the cart. Match each vial to its own Certificate of Analysis when a lot is published. Research use only. Not for human or veterinary use.

References

This note does not add a separate citation list. Named papers, when the body links them, stay in the text above.

Research use only. BlueNex Labs does not provide medical or veterinary advice. Confirm your institution’s policies before purchase. Lot-file rules for this note are on the documentation standards page. Scientific lead: Alice Kay, Ph.D.